ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Bicycle Therapeutics PLC

Bicycle Therapeutics PLC (BCYC)

25.41
-0.09
(-0.35%)
Closed September 22 4:00PM
25.25
-0.16
(-0.63%)
After Hours: 7:21PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
25.25
Bid
24.80
Ask
25.70
Volume
474,664
24.82 Day's Range 26.3798
0.00 52 Week Range 0.00
Market Cap
Previous Close
25.50
Open
25.50
Last Trade Time
Financial Volume
$ 12,031,759
VWAP
25.348
Average Volume (3m)
-
Shares Outstanding
68,993,458
Dividend Yield
-
PE Ratio
-9.67
Earnings Per Share (EPS)
-2.62
Revenue
26.98M
Net Profit
-180.66M

About Bicycle Therapeutics PLC

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused... Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, Gbr
Founded
-
Bicycle Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCYC. The last closing price for Bicycle Therapeutics was $25.50. Over the last year, Bicycle Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Bicycle Therapeutics currently has 68,993,458 shares outstanding. The market capitalization of Bicycle Therapeutics is $1.76 billion. Bicycle Therapeutics has a price to earnings ratio (PE ratio) of -9.67.

Bicycle Therapeutics (BCYC) Options Flow Summary

Overall Flow

Bullish

Net Premium

63k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

BCYC Latest News

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Updated monotherapy data for Nectin-4 targeting zelenectide pevedotin in metastatic urothelial cancer (mUC) showed a promising 45% overall response rate (ORR), 11.1 months median duration of...

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on September 3, 2024, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards...

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Four abstracts containing data updates across clinical pipeline accepted for poster presentation at ESMO Congress 2024 Focused R&D pipeline on clinical programs and research areas that have...

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics plc (NASDAQ: BCYC) today announced that on August 1, 2024, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards...

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNZIBanzai International Inc
$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
$ 116.00
(-1.59%)
378.16M
AAPLApple Inc
$ 228.20
(-0.29%)
320.24M
INTCIntel Corporation
$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
$ 0.0742
(33.45%)
178.65M

Your Recent History

Delayed Upgrade Clock